Huxley Medical, Inc. announced the SANSA(R) home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, ...

Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial release of central sleep apnea (CSA) detection for its SANSA(R) home sleep apnea test.

Quality improvement programs markedly increase sleep apnea testing in stroke patients, showing effective ways to improve guideline-based care. A structured quality improvement (QI) program led to a ...

Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. | Resmed believes ...

With a career in helping Paducah residents find better sleep, one local surgeon is recognized for his work treating ...

In a new clinical trial, people with obesity and knee osteoarthritis who took an experimental drug from Eli Lilly lost large ...

Audrey Stetson and John Redfield stop by Rest Up Sleep Solutions in Escanaba to learn about dental appliances that can ...

Older adults with a combination of insomnia and obstructive sleep apnea demonstrated worse sleep and verbal memory ...

Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on sleep related breathing disorders, including obstructive sleep ...

Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach December 16, 2025 11:00 ...

Compared with the outpatient setting, there is a lack of guidance on diagnosing, managing and treating obstructive sleep ...

As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease ...